Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

March 10, 2023

Conditions
Anesthesia
Interventions
DRUG

Esketamine 0.2mg/kg

"Patients received 0.2 mg/kg of esketamine intravenously for 30 s,after 120 s of propofol and disappearance of the eyelash reflex, a laryngeal mask was inserted.~The test was performed using the sequential method. The initial dose of propofol was 2 mg/kg, which can be easily inserted into the LMA, and the propofol dose ratio of the adjacent patient was 0.9. If there was a positive reaction to the LMA insertion, the gradient was increased for the next patient; otherwise, the gradient was decreased, and the study was terminated after seven crossover inflection points."

DRUG

Esketamine 0.3mg/kg

"Patients received 0.3 mg/kg of esketamine intravenously for 30 s,after 120 s of propofol and disappearance of the eyelash reflex, a laryngeal mask was inserted.~The test was performed using the sequential method. The initial dose of propofol was 2 mg/kg, which can be easily inserted into the LMA, and the propofol dose ratio of the adjacent patient was 0.9. If there was a positive reaction to the LMA insertion, the gradient was increased for the next patient; otherwise, the gradient was decreased, and the study was terminated after seven crossover inflection points."

Trial Locations (1)

100049

Liang-Yuan Lu, Beijing

All Listed Sponsors
lead

Aerospace Center Hospital

OTHER